People · Operator
Named in public records as an officer, director or promoter · active 2009–2023 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Dare Bioscience, Inc. | — | Biotechnology | Series B | $102.0M | $93.8M | 2023 |
| MicroCHIPS, Inc. | — | Biotechnology | Series B | $27.9M | $740.1M | 2015 |
| Isto Technologies Inc | — | Biotechnology | Series A | $21.1M | $88.9M | 2009 |
| Elute, Inc. | — | Pharmaceuticals | Seed | $1.6M | $62.2M | 2016 |
Cheryl R. Blanchard at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Cheryl R. Blanchard on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Langer | 2 | 36 |
| Michael Greeley | 1 | 15 |
| Robert S Langer | 1 | 14 |
| Tara Butler | 1 | 12 |
| John P Ryan | 1 | 11 |
| Alan Crane | 1 | 9 |
| Terrance McGuire | 1 | 9 |
| Terry McGuire | 1 | 8 |
| Robert Crane | 1 | 7 |
| Robert Tepper | 1 | 7 |
| TERRANCE G. MCGUIRE | 1 | 7 |
| Bryan E. Roberts | 1 | 6 |
| John Santini | 1 | 5 |
| George Dunbar | 1 | 5 |
| Steven E. Hall | 1 | 4 |
| Alexandra Glucksmann | 1 | 4 |
| Robert E. Langer | 1 | 3 |
| Stephen Oesterle | 1 | 3 |
| James M. Stolze | 1 | 2 |
| ASHOK C. KHANDKAR | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.